Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
OA02 - A New Vision of Targets and Strategies
- 10:30 - 12:00
- 9/08/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Oral Session
- Track: Targeted Therapy
- Moderators:Frank Griesinger, Luis Paz-Ares
-
+
OA02.07 - Phase 3 ALUR Study of Alectinib in Pretreated ALK+ NSCLC: Final Efficacy, Safety and Targeted Genomic Sequencing Analyses
11:35 - 11:45 | Presenter: Juergen Wolf | Author(s): Åslaug Helland, In-Jae Oh, Maria Rita Migliorino, Rafal Dziadziuszko, Javier De Castro Carpeno, Julien Mazieres, Frank Griesinger, Marijana Chlistalla, Andres Cardona, Thorsten Ruf, Kerstin Trunzer, Vlatka Smoljanovic, Silvia Novello
- Abstract
Loading...
-
+
MA05 - Update on Clinical Trials and Treatments
- 13:30 - 15:00
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Mesothelioma
- Moderators:Seiki Hasegawa, Enrico Ruffini, Angel Artal
-
+
MA05.05 - Post-Discontinuation Treatments in IFCT-GFPC-0701 MAPS Trial: Real-World Effectiveness of 2nd-Line (2L) Treatments for Mesothelioma
14:00 - 14:05 | Presenter: Gerard Zalcman | Author(s): Solene Brosseau, Julien Mazieres, Jacques Margery, Laurent Greillier, Clarisse Audigier-Valette, Denis Moro-Sibilot, Olivier Molinier, Romain Corre, Isabelle Monnet, Valérie Gounant, Frédéric Rivière, Radj Gervais, Henri Janicot, Chrystele Locher, Alexandra Langlais, Jean-Jacques Parienti, Franck Morin, Arnaud Scherpereel
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-108 - PACIFIC-6: A Phase II Study of Durvalumab Following Sequential Chemoradiotherapy in Patients with Stage III, Unresectable NSCLC
09:45 - 09:45 | Presenter: Marina Chiara Garassino | Author(s): Corinne Faivre-Finn, Julien Mazieres, Martin Reck, Ugochi Emeribe, April Franks, Nataliya Trunova
- Abstract
Loading... -
+
P1.01-120 - Immune Checkpoint Inhibitors Versus Second Line Chemotherapy for Patients with Lung Cancer Refractory to First Line Chemotherapy
09:45 - 09:45 | Presenter: Corentin Lefebvre | Author(s): Elodie Martin, Lizza Hendriks, Remi Veillon, Thomas Filleron, Florent Puisset, Laura Mezquita, Roberto Ferrara, Mireille Sabatier, Benjamin Besse, Anne Marie Clasina Dingemans, Julien Mazieres
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-30 - Pioneer Study: Precision Immuno-Oncology for Advanced Non-Small Cell Lung Cancer Patients with PD1/L1 ICI Resistance
09:45 - 09:45 | Presenter: Fabrice Barlesi | Author(s): David Pérol, Julien Mazieres, Maurice Perol, Nathalie Varoqueaux, Florence Monville, Clarisse Audigier-Valette, Patricia Barre, François Domergue, Lionel Falchero, Cyril Foa, Ahmed Frikha, Stéphane Hominal, Jacques Le Treut, Sarah Zahi, Marie Roumieux, Daniel Olive, Eric Vivier
- Abstract
Loading...
-
+
P1.16 - Treatment in the Real World - Support, Survivorship, Systems Research
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
P1.16-46 - Genetic Testing Patterns, Treatment Characteristics, and Overall Survival in ALK-Positive Metastatic NSCLC Patients Treated with Ceritinib
09:45 - 09:45 | Presenter: Julien Mazieres | Author(s): Myung-Ju Ahn, Christos Chouaid, Anna Kron, Juergen Wolf, Ravi K. Goyal, Keith L Davis, Maurice Perrinjaquet, Timothy Pham, Stefanie Knoll
- Abstract
Loading...
-
+
OA08 - Advanced Models and "Omics" for Therapeutic Development
- 11:00 - 12:30
- 9/09/2019
- Location: Interlaken (1988)
- IASLC CME Accredited
- Type: Oral Session
- Track: Biology
- Moderators:Luis M Montuenga, Julie George
-
+
OA08.05 - Notch Inhibition Overcomes Resistance to Tyrosine Kinase Inhibitors Promoted by Gate-Keeper Mutations in EGFR-Driven Lung Adenocarcinoma
11:40 - 11:50 | Presenter: Antonio Maraver | Author(s): Emilie Bousquet, Xavier Quantin, Jean Louis Pujol, Kwok-Kin Wong, Jean-Charles Soria, Julien Mazieres, Luis Paz-Ares
- Abstract
Loading...
-
+
MA12 - New Frontiers from Pathology to Genomics
- 14:00 - 15:30
- 9/09/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Mesothelioma
- Moderators:Prasad S Adusumilli, Francisco Perez Ochoa
-
+
MA12.01 - Redefining Malignant Pleural Mesothelioma Types as a Continuum Uncovers Immune-Vascular Interactions
14:00 - 14:05 | Presenter: Matthieu Foll | Author(s): Nicolas Alcala, Lise Mangiante, Nolwenn Le Stang, Corinne Gustafson, Sandrine Boyault, Francesca Damiola, Karine Alcala, Julien Mazieres, Jean-Yves Blay, Sylvie Lantuejoul, Raphael Bueno, Christopher Caux, Nicolas Girard, James McKay, Francoise Galateau Sallé, Lynnette Fernandez-Cuesta
- Abstract
Loading...
-
+
PC02 - Combining with Chemo: Old School Is New Again
- 14:00 - 15:30
- 9/09/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Pro-Con Session
- Track: Advanced NSCLC
- Moderators:Julien Mazieres, Javier De Castro Carpeno
-
+
PC02.01 - TKIs Should Be Given as Single Agent
14:00 - 14:20 | Presenter: Tony Mok
- Abstract
No abstract available for this presentation
-
+
PC02.02 - TKIs Should Be Given with Chemo
14:20 - 14:40 | Presenter: Rafael Rosell
- Abstract
Loading... -
+
PC02.03 - IO Should Be Given as a Single Agent
14:40 - 15:00 | Presenter: Julie R Brahmer
- Abstract
Loading... -
+
PC02.04 - IO Should Be Given with Chemo
15:00 - 15:20 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
PC02.05 - Q&A
15:20 - 15:30
- Abstract
No abstract available for this presentation
-
+
MA21 - Non EGFR/MET Targeted Therapies
- 14:30 - 16:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Benjamin Besse, Michael Thomas
-
+
MA21.07 - Circulating Tumor DNA Analysis Depicts Potential Mechanisms of Resistance to BRAF-Targeted Therapies in BRAF+ Non-Small Cell Lung Cancer
15:10 - 15:15 | Presenter: Sandra Ortiz-Cuaran | Author(s): Laura Mezquita, Aurélie Swalduz, Mihaela Aldea, Julien Mazieres, CECILE Jovelet, Washington René Chumbi Flores, LUDOVIC Lacroix, Yohan Loriot, Luc Friboulet, Virginie Westeel, Maud Ngocamus, Anne Pradines, Claire Tissot, Christelle Clement Duchene, Christine Raynaud, Xavier Quantin, Radj Gervais, Etienne Brain, Isabelle Monnet, Etienne Giroux Leprieur, Virginie Avrillon, Céline Mahier-Aït Oukhatar, Natalie Hoog-Labouret, Frank De Kievit, Karen Howarth, Jean-Francois Guichou, Clive Morris, Emma Green, Maurice Perol, Benjamin Besse, Jean-Yves Blay, Pierre Saintigny, David Planchard
- Abstract
Loading...